Pharmafile Logo

News and Press Releases

ERS Genomics and Université de Montréal sign CRISPR/Cas9 license agreement

License agreement provides Université de Montréal access to CRISPR gene editing technology for use across its platform services 1 October 2024 -- Dublin, Ireland, and Montreal, Canada -- ERS Genomics...

Category: Biotechnology, Clinical Trials, Drug Discovery
Posted: October 1, 2024

ERS Genomics
8th Floor, Block E, Iveagh Court, Harcourt Road, Dublin D02 YT22, Ireland

ERS Genomics and Medicines Discovery Catapult sign CRISPR/Cas9 license agreement

Partnership provides Medicines Discovery Catapult access to CRISPR gene editing technology across a broad range of drug discovery applications 04 September 2024 – Dublin, Ireland, and Cheshire, UK – ERS...

Category: BioManufacturing
Posted: September 9, 2024

ERS Genomics
8th Floor, Block E, Iveagh Court, Harcourt Road, Dublin D02 YT22, Ireland

ERS Genomics and IRBM sign CRISPR/Cas9 license agreement

License agreement provides IRBM access to CRISPR gene editing technology to be applied across its drug discovery services offering 20 May 2024 -- Dublin, Ireland, and Rome, Italy -- ERS...

Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: May 20, 2024

ERS Genomics
8th Floor, Block E, Iveagh Court, Harcourt Road, Dublin D02 YT22, Ireland

ERS Genomics appoints John E Milad as Chief Executive Officer

13 May 2024 -- Dublin, Ireland -- ERS Genomics, the CRISPR licensing company, today announced the appointment of John E Milad as CEO, with immediate effect. John brings over 25...

Category: Drug Delivery, Drug Discovery
Posted: May 13, 2024

ERS Genomics
8th Floor, Block E, Iveagh Court, Harcourt Road, Dublin D02 YT22, Ireland

Ricoh and ERS Genomics enter into CRISPR/Cas9 license agreement

CRISPR/Cas9 genome editing technology contributes to the expansion of the creation of novel disease model 13 March 2024 -- Tokyo, Japan, and Dublin, Ireland -- Ricoh Company today announced a...

Category: Biotechnology
Posted: March 13, 2024

ERS Genomics
8th Floor, Block E, Iveagh Court, Harcourt Road, Dublin D02 YT22, Ireland

Broken String Biosciences’ INDUCE-seq platform demonstrates impact of structural DNA changes on specificity of CRISPR-Cas9 gene editing

Research published in Molecular Cell used INDUCE-seq to identify DNA topology as an important regulator of CRISPR targeting specificity Peer-reviewed data demonstrates the sensitivity of INDUCE-seq DNA break mapping platform,...

Category: Biotechnology
Posted: October 18, 2023

Broken String Biosciences
info@brokenstringbio.com
Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR